| Operations and Assets for Operating Segments and Geographic Information |
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the years ended December 31, |
(In thousands) |
2015 |
|
2014 |
|
2013 |
Revenue from services: |
|
|
|
|
|
Pharmaceutical |
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
Diagnostics |
329,599 |
|
|
8,426 |
|
|
10,833 |
|
Corporate |
140 |
|
|
240 |
|
|
825 |
|
|
$ |
329,739 |
|
|
$ |
8,666 |
|
|
$ |
11,658 |
|
Product revenues: |
|
|
|
|
|
Pharmaceutical |
$ |
80,146 |
|
|
$ |
76,983 |
|
|
$ |
68,161 |
|
Diagnostics |
— |
|
|
— |
|
|
— |
|
Corporate |
— |
|
|
— |
|
|
— |
|
|
$ |
80,146 |
|
|
$ |
76,983 |
|
|
$ |
68,161 |
|
Revenue from transfer of intellectual property: |
|
|
|
|
|
Pharmaceutical |
$ |
81,853 |
|
|
$ |
5,285 |
|
|
$ |
15,160 |
|
Diagnostics |
— |
|
|
191 |
|
|
1,551 |
|
Corporate |
— |
|
|
— |
|
|
— |
|
|
$ |
81,853 |
|
|
$ |
5,476 |
|
|
$ |
16,711 |
|
Operating (loss) income: |
|
|
|
|
|
Pharmaceutical |
$ |
(40,395 |
) |
|
$ |
(94,401 |
) |
|
$ |
(29,809 |
) |
Diagnostics |
(10,294 |
) |
|
(21,647 |
) |
|
(22,199 |
) |
Corporate |
(46,512 |
) |
|
(27,725 |
) |
|
(24,473 |
) |
Less: Operating loss attributable to noncontrolling interests |
(1,280 |
) |
|
(2,042 |
) |
|
(3,151 |
) |
|
$ |
(98,481 |
) |
|
$ |
(145,815 |
) |
|
$ |
(79,632 |
) |
Depreciation and amortization: |
|
|
|
|
|
Pharmaceutical |
$ |
10,245 |
|
|
$ |
7,936 |
|
|
$ |
8,234 |
|
Diagnostics |
31,918 |
|
|
6,894 |
|
|
6,833 |
|
Corporate |
85 |
|
|
97 |
|
|
149 |
|
|
$ |
42,248 |
|
|
$ |
14,927 |
|
|
$ |
15,216 |
|
Net loss from investment in investees: |
|
|
|
|
|
Pharmaceutical |
$ |
(7,105 |
) |
|
$ |
(3,587 |
) |
|
$ |
(11,456 |
) |
Diagnostics |
— |
|
|
— |
|
|
— |
|
Corporate |
— |
|
|
— |
|
|
— |
|
|
$ |
(7,105 |
) |
|
$ |
(3,587 |
) |
|
$ |
(11,456 |
) |
Revenues: |
|
|
|
|
|
United States |
$ |
344,464 |
|
|
$ |
14,142 |
|
|
$ |
28,369 |
|
Ireland |
78,989 |
|
|
— |
|
|
— |
|
Chile |
29,885 |
|
|
29,154 |
|
|
31,650 |
|
Spain |
16,622 |
|
|
21,323 |
|
|
18,800 |
|
Israel |
18,107 |
|
|
20,638 |
|
|
13,252 |
|
Mexico |
3,671 |
|
|
5,807 |
|
|
4,459 |
|
Other |
— |
|
|
61 |
|
|
— |
|
|
$ |
491,738 |
|
|
$ |
91,125 |
|
|
$ |
96,530 |
|
|
|
|
|
|
|
|
|
|
(In thousands) |
December 31,
2015 |
|
December 31,
2014 |
Assets: |
|
|
|
Pharmaceutical |
$ |
1,258,011 |
|
|
$ |
1,064,498 |
|
Diagnostics |
1,479,841 |
|
|
108,072 |
|
Corporate |
61,762 |
|
|
95,094 |
|
|
$ |
2,799,614 |
|
|
$ |
1,267,664 |
|
Goodwill: |
|
|
|
Pharmaceutical |
$ |
251,225 |
|
|
$ |
173,327 |
|
Diagnostics |
492,123 |
|
|
50,965 |
|
Corporate |
— |
|
|
— |
|
|
$ |
743,348 |
|
|
$ |
224,292 |
|
|